PERAN LEMAK EPIKARDIAL PADA PENYAKIT JANTUNG KORONER STABIL
Abstract
Visceral fat tissue widely known have endocrine function by secreting Cytokines that provide it function in metabolism of visceral organ such as heart. It function have pivotal role under physiology and patology condition by secreting antiinflamatory cytokines in physiology condition, otherwise proinflammatory cytokines in patology condition. Epicardial fat tissue as regard this function, have more important role to the heart, because it have two advantage than other visceral depots. First, this tissue have same microcirculation provided by small branch of coronary arteries, and second it were not boundary by any structure. Recent studies found that there were correlation between increased epicardial fat depot and coronary artery disease. It seems correlate with this unique structure and function. This literature review focuse on how is the role of epicardial fat tissue in atheroschlerotic process especially in coronary artery.
Keywords
Full Text:
PDFReferences
RISKESDAS. Riset Kesehatan Dasar (RISKESDAS) Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan Republik Indonesia Jakarta: Kementrian Kesehatan RI; 2013: 384.
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics--2013 update : a report from the American Heart Association. Circulation. 2013;127:e19.
Prasetya M, Oenzil F and Karani Y. Hubungan Indeks Masa Tubuh dan Lingkar Perut dengan Low Density Lipoprotein pada Pasien Penyakit Jantung Koroner di Poliklinik Jantung RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas. 2015;4:737-742.
Nagy E, Jermendy AL, Merkely B and Maurovich-Horvat P. Clinical importance of epicardial adipose tissue. Archieve of Medical Science. 2016;13:858.
Patel VB, Shah S, Verma S and Oudit GY. Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease. Heart Failure Reviews. 2017:4-8.
Sherwood L. Human Physiology: From Cells to Systems. In: L. Sherwood, ed. Energy Balance and Temperature Regulation. 9 ed. Boston: Cengage Learning; 2016: 618-637.
Rietdorf K and MacQueen H. Investigating interactions between epicardial adipose tissue and cardiac myocytes: what can we learn from different approaches? British Journal of Pharmacology. 2016; 174 3542–3560.
Sarantopoulos CN, Banyard DA, Ziegler ME, Sun B, Shaterian A and Widgerow AD. Elucidating the Preadipocyte and Its Role in Adipocyte Formation: a Comprehensive Review. Stem Cell Review and Report 2017:1-16.
Iacobellis G and Sharma AM. Epicardial Adipose Tissue As New Cardio-Metabolic Risk Marker and Potential Therapeutic Target in the Metabolic Syndrome. Current Pharmaceutical Design. 2007;13:2180-2184.
Wu Y, Zhang A, Hamilton DJ and Deng T. Epicardial Fat in the Maintanance of Cardiovascular Health. Methodist DeBakey Cardiovascular Journal. 2017;13:20-24.
Turer At and Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012;55:2319–2326.
Iacobellis G and Bianco AC. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends in Endocrinology and Metabolism. 2011;22:450-457.
Gaborit Bee, Sengenes C, Ancel P, Jacquier A and Dutour A. Role of Epicardial Adipose Tissue in Health and Disease: A Matter of Fat? Comprehensive Physiology. 2017;11:1060-69.
Ouchi N, Parker JL, Lugus JJ and Walsh K. focus on metabolism and immunology: Adipokines in inflammation and metabolic disease. Immunology. 2011;11:84-94.
Vianello E, Dozio E, Arnaboldi F, Gnes M, Marazzi, Martinelli C, et al. Epicardial adipocyte hypertrophy: Association with M1-polarization and toll-like receptor pathways in coronary artery disease patients. Nutrition, Metabolism & Cardiovascular Diseases 2016;26:246-253.
Matloch Z, Kotulak T and Haluzik M. The role of epicardial adipose tissue in heart disease. Physiology Research. 2016;65:23-32.
Jia G, Jia Y and Sowers JR. Contribution of Maladaptive Adipose Tissue Expansion to Development of Cardiovascular Disease. Comprehensive Physiology. 2017;7:253-262.
Despre´s J-P. Body Fat DIstribution and Risk of Cardiovascular Disease: An Update. Circulation. 2012;126:1301-1313.
Jermendy AL, Kolossvary M, Drobni, Tarnoki, Tarnoki, Karady J, et al. Assessing genetic and environmental influences on epicardial and abdominal adipose tissue quantities: A classical twin study. International Journal of Obesity accepted article preview 30 August 2017; doi: 10.1038/ijo.2017.212.:1-31.
Sun K, Tordjman J, Clémen K and Scherer PE. Fibrosis and Adipose Tissue Dysfunction. Cellular Metabolism 2013;18:470–477.
Barnes JL and Gorin Y. MYofibroblast DIfferentiation During Fibrosis: Role of NAD(P)H oxidases. Kidney International. 2011;79:944-956.
International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. 2005:1-7.
Zhang C, Rexrode KM, Dam RMv, Li TY and Hu FB. Abdominal Obesity and the Risk of All-Cause, Cardiovascular, and Cancer Mortality. Circulation. 2008;117: 1658-67.
Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.
Gelber RP, Gaziano M, Orav J, Manson, Buring JE and Kurth T. Measures of obesity and cardiovascular risk among men and women. Journal of American College of Cardiology. 2008;52:605–615
.
Rabkin SW. The Relationship Between Epicardial Fat and Indices of Obesity and the Metabolic Syndrome: A Systematic Review and Meta-Analysis. METABOLIC SYNDROME AND RELATED DISORDERS. 2013;12:31-42.
DOI: http://dx.doi.org/10.32883/hcj.v5i2.780
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
HUMAN CARE JOURNAL
Published by Universitas Fort De Kock, Bukittinggi, Indonesia
© Human Care Journal e-ISSN : 2528-665X P-ISSN : 2685-5798